Understanding FDA Cuts and Their Impact on Device Developers
Thursday, 3 April 2025, 16:02
FDA cuts raise concerns among device developers as Jeff Shuren, the former CDRH Director, highlights potential repercussions. Longer review times may become a reality, impacting innovation. Shuren's insights shed light on this critical issue faced by the medical device industry.
This article was prepared using information from open sources in accordance with the principles of Ethical Policy. The editorial team is not responsible for absolute accuracy, as it relies on data from the sources referenced.